marijuana stocks news

Form 8-K for INSYS THERAPEUTICS, INC.


6-Aug-2015

Results of Operations and Financial Condition, Financial Statements and

Item 2.02 Results of Operations and Financial Condition.On August 6, 2015, Insys Therapeutics, Inc. (the “Company”) issued a press release announcing its financial results for the first quarter ended June 30, 2015. A copy of this press release is attached hereto as Exhibit 99.1.

The information in this Item 2.02 and Exhibit 99.1 hereto are being furnished and shall not be deemed “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liability of that section, nor shall they be deemed incorporated by reference into any filing under the Exchange Act or the Securities Act of 1933, as amended, except as expressly set forth by specific reference in such a filing.

 

Item 9.01 Financial Statements and Exhibits.(d) Exhibits.

Exhibit
No. Description

99.1 Press Release dated August 6, 2015


MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

Verano Holdings Corp. (VRNOF) Elevates Florida Retail Footprint to 79 Dispensaries

Verano Elevates Florida Retail Footprint to 79 Dispensaries with the Openings of…

Charlotte’s Web Holdings, Inc. (CWBHF) to Host Virtual Annual General & Special Meeting of Shareholders on

Charlotte’s Web to Host Virtual Annual General & Special Meeting of Shareholders…

AbbVie Inc. (ABBV) RINVOQ® (upadacitinib) Met Primary and All Ranked Secondary Endpoints in Phase 3 Study

AbbVie’s RINVOQ® (upadacitinib) Met Primary and All Ranked Secondary Endpoints in Phase…

$EAPH Announces Receipt of Preliminary Proposal

Easton Pharmaceuticals Announces Receipt of Preliminary Proposal From Major Multi National Pharmaceutical…